All News

ACOG warns that CMS’ proposed G-codes for 2027 would create a dual maternity billing system, worsening disparities while increasing confusion.

Roche's cobas BV/CV assay received FDA clearance as a single-swab test for bacterial vaginosis and candida vaginitis.

Damian Alagia, III, MD, attributes gaps in prenatal STI detection and treatment to systemic flaws in access rather than individual clinical judgment.

ACOG's updated guidance calls for opt-out HIV testing and proactive PrEP counseling from ob-gyns.

Lisa A. Bukovac, DO, FACOG, explains how placental biomarker testing can identify which patients with suspected preeclampsia require hospitalization and which can be safely monitored.

A scoping review presented at ACOG 2026 by Calbeth C. Alaribe, DMSc, MPH, PA-C, found no studies examining the association between preeclampsia, eclampsia, and endometriosis among Black women.

New York’s Safe Motherhood Initiative bundle coincided with drops in SMM, DIC, and hysterectomy after postpartum hemorrhage.

Connor Frey, MD, explains why semaglutide and tirzepatide, but not liraglutide, generated menstrual adverse event signals in a FAERS pharmacovigilance analysis.

Damian Alagia, III, MD, joined Contemporary OB/GYN for a discussion on STIs in women, associated stigma, and structural barriers to testing.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Appelbaum frames surgery as one component of endometriosis intervention, stressing ongoing postsurgical treatment given the chronic nature of the disease.

CDC data show 15.2% of US pregnant women reported current alcohol use in 2021-2024, up from 13.5% in 2018-2020.

ACOG, SWHR, and WFRC are calling on Congress to invest $20B over 10 years to close the women's health gap.

Heather Appelbaum, MD, FACOG, explains how distinguishing clinical from surgical diagnosis of endometriosis can enable earlier intervention, in a discussion of her NASPAG presentation.

According to Beth Ann Clayton, DNP, CRNA, FAANA, FAAN, maintaining patients with substance use disorder on methadone or buprenorphine is a critical component of preoperative planning.

IGFBP4/SHBG screen-guided care cut NICU admissions from 16.4% to 12.8% in nulliparous PRIME trial participants.

One in 3 US women aged 35 and older is unsure if they’re in perimenopause, driven by symptom confusion and care barriers.

Kate McLean, MD, describes how newly defined bacterial vaginosis subtypes could validate patient symptoms and inform treatment.

Alcohol use increased from 8% to 44% postpartum among pregnant people with HIV, with distinct risk factors identified for alcohol vs cannabis use.

The phase 4 study's oversampling of moderate PPD patients, showing a nearly 9-point EPDS drop by day 15, helps close a gap left by trials that enrolled predominantly severe cases.

Roshni Koli, MD, describes how embedding mental health care within the ob-gyn setting drove high engagement and rapid symptom remission in a perinatal collaborative care study.

A large Korean birth cohort found a modest relative increase in pediatric IBD and Crohn disease risk after prenatal PPI/H2RA exposure, but absolute risk differences were under 1 case per 1000 children.

A pilot trial found nicotinamide riboside and pterostilbene cut hot flashes, bloating, and poor sleep by 50% or more in 7 days.

A recent mediation analysis shows 54% of elinzanetant's (Lynkuet) sleep benefit is independent of nighttime VMS reduction, suggesting NK1 blockade targets menopausal sleep disruption through a distinct pathway.

A retrospective study found that a tech-enabled perinatal collaborative care program delivered within an OB/GYN practice was associated with reductions in depression and anxiety symptoms.

Maegan Ashworth Dirac, MD, PhD, explains how COVID-19 infection risk and low vaccine uptake among pregnant women contributed to a rise in indirect maternal deaths worldwide.

A qualitative sub-study of the COMPASS+ Trial published in Pregnancy found that the Collaborative Care Model is well suited to obstetric settings but requires context-specific adaptation to overcome multilevel barriers.

Progress slowed in 120 of 204 countries during 2015–2023 versus 2000–2015, explains Maegan Ashworth Dirac, MD, PhD, who attributes the largest gains to either broad development or targeted maternal care investments.